Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV005332808 | SCV005993759 | uncertain significance | not specified | 2025-03-06 | criteria provided, single submitter | clinical testing | The c.1308C>G (p.F436L) alteration is located in exon 9 (coding exon 9) of the ABCA2 gene. This alteration results from a C to G substitution at nucleotide position 1308, causing the phenylalanine (F) at amino acid position 436 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |